10-07/08 :: July/August 2010

nanotimes

Companies Facts

round. The Atlanta-based company designs and ma- nufactures linear position sensing products for moti- on control manufacturers. http://www.sentrinsic.com

A S

hrink Nanotechnologies, Inc. (Shrink, OTCBB: INKN) has entered into a technology integrati-

on and development agreement with Lydall, Inc. (NYSE: LDL). Under the terms of the agreement, Lydall will provide Shrink with certain quantities of its Solupore®

thermoplastic membrane for the pur-

pose of conducting a one-year research and develop- ment project. The goal of the project is to develop a robust, ultra-rapid diagnostic platform that increases the sensitivity of fluorescent-based assays by integra- ting Solupore technology with Shrink‘s rapid proto- typing system, ShrinkChip Manufacturing System™ and NanoPetal™ technology. Under the terms of the agreement, any ownership of new intellectual pro- perty will be based on inventorship. Mark L. Baum, CEO of Shrink Nanotechnologies, sta- ted, “This new relationship with Lydall is part of our effort to turn our NanoShrink materials into viable systems used in critical point-of-care and point-of- operations products. The market for these types of sensors is in the billions of US Dollars in annual sales, and they are used in a wide range of commercial applications such as food safety, personalized drug therapies and disease screening, to name a few. By producing more of the overall system solution, with the integration of the Lydall Solupore®

material, we

seek to increase the flexibility and scope of these im- portant diagnostic devices and in turn open the door to future strategic partnerships with leading research laboratories in industry and academia.”

ccording to an SEC filing, Sentrinsic Inc. has closed on $500,018 in an equity financing

Shrink Nanotechnologies announced further the formation a new wholly-owned subsidiary, Shrink Chips LLC, which is dedicated to the commerciali- zation of a suite of next-generation biotechnology research tools, including its patent-pending Shrink- Chip Rapid Prototyping System (RPS) which is used to inexpensively and flexibly manufacture microflui- dic chips, or Lab-on-a-Chip (LOC), devices as well as many other biological and chemical sensors. Shrink announced further that certain patent appli- cations related to its advanced tissue engineering technology platform, CellAlign™, have been filed. CellAlign’s key feature is a micro-fabricated substrate with non-periodic (or random) linear patterned groo- ves that allow for the alignment of cells along a single axis. The unique design is ideal for growing biological tissues from stem cells, especially those that naturally grow in a linear fashion such as in cardiac and nerve tissues.

http://www.lydall.com http://www.shrinknano.com

S S

olazyme, Inc., a renewable oil production company and leader in algal biotechnology, has

raised $52 million in its Series D financing round. Solazyme uses microbial fermentation to produce renewable oil that can be used for clean and scala- ble fuels, chemicals, nutritional food ingredients and health and wellness products. http://www.solazyme.com

olexant Corp., developer of third-generation ultrathin-film PV technology, announced the

selection of the city of Gresham, Oregon, USA, for the location of its first commercial-scale nanocry- stal manufacturing facility. Upon completion, the

35